help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beranek, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beranek, J. T.
(American Journal of Pathology. 2002;160:1543-1544.)
© 2002 American Society for Investigative Pathology


Correspondence

Tissue Factor Identifies Cardiomyocyte Apoptotic Bodies in Reperfusion Injury

Jiri T. Beranek

Columbia, Missouri

To the Editor-in-Chief:

A delayed reaction to published research occurs when new advances permit a novel look at previously accepted concepts.1,2 This explains my interest in the article by Erlich et al3 about the influence of tissue factor-thrombin pathway on myocardial ischemia-reperfusion injury. Using rabbits, the authors created ischemia in the region supplied by the anterolateral branch of the left main coronary for 45 minutes and reperfused the ischemic region for 2 hours. At the end of the experiments, the animals were sacrificed and studied morphologically.

In Figure 5A of the article by Erlich et al,3 an area of ischemic and reperfused myocardium is identified by acid-fuchsin staining. It contains numerous myocardial defects, indicating that the myocardium has not only been heavily damaged but that numerous cardiomyocytes have also disappeared. What was the mechanism of their destruction? Accidental death, sometimes called necrosis, may be excluded because of the shortness of time. Only apoptosis comes into consideration. Sessile macrophages are able to phagocytize apoptotic bodies of a cardiomyocyte in a few hours. It is doubtful, however, that they would be able to create myocardial defects so numerous and large in such a short time as in Figure 5A without the help of their counterparts from blood and the bone marrow. Being a part of chronic inflammatory reaction, the intervention of blood and bone marrow macrophages may also be excluded by reason of the shortness of time. There is only one possibility left which is cardiomyocyte apoptosis and the elimination of apoptotic bodies by lymphatic outflow.4

In Figure 5A, myocardial defects contain small particles which may be red cells or cardiomyocyte apoptotic bodies.5 The answer to this question may be found in Figure 5, B and C, which also visualize ischemic and reperfused areas. There, it is distinctly visible that: tissue factor is located not only in the sarcolemma and intercalated disks but also in cardiomyocyte cytoplasm; the same particles as those in myocardial defects are also present inside clearly recognizable fragmenting cardiomyocytes; and any of these particles contain tissue factor. Consequently, a majority of them are not red cells but cardiomyocyte apoptotic bodies.

Small eosinophilic particles present in histological slides of cardiac hyperacute rejection1 and reperfusion injury5 have usually been considered to be red cells forming interstitial hemorrhage. We have observed, however, that their appearance is almost always accompanied by a disappearance of cardiomyocytes. Having observed their formation inside fragmenting cardiomyocytes, we concluded that they derived from them eosinophilic droplets.6 Only later, we hypothesized that they were cardiomyocyte apoptotic bodies5 and that they played an important role in fundamental processes of cardiac pathology such as reperfusion injury5 and postinfarction heart rupture.7 This letter brings evidence that tissue factor may help us to distinguish between cardiomyocyte apoptotic bodies and interstitial hemorrhage.

References

  1. Beranek JT: Quick disposal of dead cardiomyocytes: an ultimate proof of their apoptosis. J Heart Lung Transplant 2001, 20:923-924[Medline]
  2. Beranek JT: Pathogenesis of heart fibrosis in systemic sclerosis. Int J Cardiol 2001, 80:261-262[Medline]
  3. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, Martin TR, Pohlman TH, Verrier ED, Mackman N: Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 2000, 157:1849-1862[Abstract/Free Full Text]
  4. Beranek JT: Thanatosomes and cardiomyocyte apoptotic bodies. Hum Pathol 2001, 32:894-895[Medline]
  5. Beranek JT: Why primary angioplasty is less offensive to the myocardium compared with thrombolysis for acute myocardial infarction. Am Heart J 2000, 140:5-6
  6. Beranek JT, Weber KT: Eosinophilic droplets associated with hyaline degeneration in the myocardium imitate red blood cells. Clin Res 1992, 40:755A (Abstract)
  7. Beranek JT: C-reactive protein in postinfarction heart rupture. Eur Heart J 1997, 18:1834-1835[Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. T. Beranek, T. El-Sawy, and R. L. Fairchild
Unusual Apoptosis in Experimental Cardiac Rejection
Am. J. Pathol., December 1, 2003; 163(6): 2640 - 2642.
[Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beranek, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beranek, J. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS